Cholesterol-lowering therapy for smokers and non-smokers: A life-table analysis

Lancet

Volumn 356, Issue 9246, 2000, Pages 2004-2006

  Bonneux, Luc ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT;

ANGINA PECTORIS; DIABETES MELLITUS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING;

EID: 0034627186     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03319-5     Document Type: Note

References (18)

1. Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: Life table method applied to health authority population
2. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease
3. Targeting lipid lowering drug therapy for primary prevention of coronary disease: An updated Sheffield table
4. Cardiovascular disease risk profiles
5. 27th Bethesda Conference: Matching the intensity of risk factor management with the hazard for coronary disease events - Task force 5: Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management
6. Prevention of coronary heart disease in clinical practice
7. Quantifying the burden of disease: The technical basis for disability-adjusted life years
8. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia: West of Scotland Coronary Prevention Study Group
9. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
10. Mortality in women and men in relation to smoking
11. Mortality from tobacco in developed countries: Indirect estimation from vital statistics
12. Mortality in relation to smoking: 40 Years' observations on male British doctors
13. Life expectancies of cigarette smokers and nonsmokers in the United States
14. Smoking and death: The past 40 years and the next 40
15. Expected gains in life expectancy from various coronary heart disease risk factor modifications
16. Stumbling into rationing